Budget Amount *help |
¥17,810,000 (Direct Cost: ¥13,700,000、Indirect Cost: ¥4,110,000)
Fiscal Year 2011: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2010: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2009: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Research Abstract |
We previously reported a splicing mutation in exon P3A of CHRNA1. We here identified that hnRNP L binds to the mutant site and suppresses splicing of exon P3A. We also reported that intravenous and intramuscular administration of AAV-COLQ to Colq-/-mice improved motor functions, as well as electrophysiological, histochemical, and biochemical features.
|